Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

5-aza-2'-deoxycytidine activates USP18. 1 / 1

| 1

➶

reach

"The online version of this article includes the following figure supplement (s) for figure 5 : Distributions of P IRF9 and P USP18 activation times in cells treated with different cell cycle perturbations.Cell cycle dependent USP18 upregulation determined by the FUCCI reporter.ISG promoters contain a wide range of CpG site numbers and methylation levels.Distributions of P IRF9 and P USP18 activation times in cells treated with decitabine.The effect of decitabine on cell cycle.Stochastic simulations with the cell-cycle gated feedback control reproduced single-cell responses to IFN pretreatments with different durations."

32945770

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...